General Information
Revision date
2009-07-16
Product name
(±)-Ibuprofen
Chemical name
Inhibitors
CAS No.
15687-27-1
Emergency telephone
Cayman Chemical Company
Icons in SDS
Company Information
company name
Cayman Chemical Company
Section 2
SECTION 2: Hazards identification
Emergency Overview: No data available.
Principle Routes of Exposure
Inhalation? Yes Skin? Yes Eyes? Yes Ingestion? Yes Other: Injection
Potential health effects
Acute and Chronic) Material is irritating to the mucous membranes and upper respiratory tract May be harmful by inhalation, ingestion, or skin absorption. May cause eye, skin, or respiratory system irritation. Possible risk of congenital malformation in the fetus. Prolonged or repeated exposure may cause allergic reactions in certain sensitive individuals. The toxicological properties of this compound have not been fully evaluated. LD 50 / LC 50: Please refer to Section 11 Signs and Symptoms Of Exposure: Clinical trials have shown the following possible adverse reactions: gastrointestinal disturbances including nausea, vomiting, cramps, diarrhea, consitpation, bloating, central nervous system effects which include dizziness, headache, depression, insomnia, aseptic meningitis, somnolence, dermatological effects of maculopapular and vesiculobullous eruptions, urticaria, alopecia, erythema multiforme, stevens-johnson syndrome, hematologic effects of neutropenia, aplastic and hemolytic anemia, thrombocytopenia, decreases in hemoglobin and hematocrit. Irritating to the skin, eyes, nose, throat, and respiratory tract.
